FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080800627> ?p ?o ?g. }

• W2080800627 endingPage "497" @default.
• W2080800627 startingPage "492" @default.
• W2080800627 abstract "To investigate post-treatment changes in serum testosterone in low- and intermediate-risk prostate cancer patients treated with hypofractionated passively scattered proton radiotherapy.Between April 2008 and October 2011, 228 patients with low- and intermediate-risk prostate cancer were enrolled into an institutional review board-approved prospective protocol. Patients received doses ranging from 70 Cobalt Gray Equivalent (CGE) to 72.5 CGE at 2.5 CGE per fraction using passively scattered protons. Three patients were excluded for receiving androgen deprivation therapy (n = 2) or testosterone supplementation (n = 1) before radiation. Of the remaining 226 patients, pretreatment serum testosterone levels were available for 217. Of these patients, post-treatment serum testosterone levels were available for 207 in the final week of treatment, 165 at the six-month follow-up, and 116 at the 12-month follow-up. The post-treatment testosterone levels were compared with the pretreatment levels using Wilcoxon's signed-rank test for matched pairs.The median pretreatment serum testosterone level was 367.7 ng/dl (12.8 nmol/l). The median changes in post-treatment testosterone value were as follows: +3.0 ng/dl (+0.1 nmol/l) at treatment completion; +6.0 ng/dl (+0.2 nmol/l) at six months after treatment; and +5.0 ng/dl (0.2 nmol/l) at 12 months after treatment. None of these changes were statistically significant.Patients with low- and intermediate-risk prostate cancer treated with hypofractionated passively scattered proton radiotherapy do not experience testosterone suppression. Our findings are consistent with physical measurements demonstrating that proton radiotherapy is associated with less scatter radiation exposure to tissues beyond the beam paths compared with intensity-modulated photon radiotherapy." @default.
• W2080800627 created "2016-06-24" @default.
• W2080800627 creator A5005329877 @default.
• W2080800627 creator A5008642709 @default.
• W2080800627 creator A5014370358 @default.
• W2080800627 creator A5015910445 @default.
• W2080800627 creator A5023899503 @default.
• W2080800627 creator A5048904323 @default.
• W2080800627 creator A5052888500 @default.
• W2080800627 creator A5053264588 @default.
• W2080800627 creator A5058130022 @default.
• W2080800627 creator A5065815535 @default.
• W2080800627 creator A5071374686 @default.
• W2080800627 date "2013-03-12" @default.
• W2080800627 modified "2023-10-14" @default.
• W2080800627 title "Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression" @default.
• W2080800627 cites W1965603638 @default.
• W2080800627 cites W1972498696 @default.
• W2080800627 cites W1975378455 @default.
• W2080800627 cites W1976832153 @default.
• W2080800627 cites W1983850632 @default.
• W2080800627 cites W1992961274 @default.
• W2080800627 cites W2007238719 @default.
• W2080800627 cites W2008700492 @default.
• W2080800627 cites W2023807811 @default.
• W2080800627 cites W2025191375 @default.
• W2080800627 cites W2038616854 @default.
• W2080800627 cites W2050457793 @default.
• W2080800627 cites W2057690904 @default.
• W2080800627 cites W2067736786 @default.
• W2080800627 cites W2068862043 @default.
• W2080800627 cites W2072746498 @default.
• W2080800627 cites W2074956774 @default.
• W2080800627 cites W2104631398 @default.
• W2080800627 cites W2109458824 @default.
• W2080800627 cites W2117830660 @default.
• W2080800627 cites W214127268 @default.
• W2080800627 cites W2144821424 @default.
• W2080800627 cites W2150780724 @default.
• W2080800627 cites W2164580629 @default.
• W2080800627 cites W2169089226 @default.
• W2080800627 cites W222878437 @default.
• W2080800627 cites W2274851081 @default.
• W2080800627 cites W2291147076 @default.
• W2080800627 cites W2396181801 @default.
• W2080800627 doi "https://doi.org/10.3109/0284186x.2013.767983" @default.
• W2080800627 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3613975" @default.
• W2080800627 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23477360" @default.
• W2080800627 hasPublicationYear "2013" @default.
• W2080800627 type Work @default.
• W2080800627 sameAs 2080800627 @default.
• W2080800627 citedByCount "13" @default.
• W2080800627 countsByYear W20808006272013 @default.
• W2080800627 countsByYear W20808006272014 @default.
• W2080800627 countsByYear W20808006272015 @default.
• W2080800627 countsByYear W20808006272016 @default.
• W2080800627 countsByYear W20808006272017 @default.
• W2080800627 countsByYear W20808006272019 @default.
• W2080800627 countsByYear W20808006272020 @default.
• W2080800627 crossrefType "journal-article" @default.
• W2080800627 hasAuthorship W2080800627A5005329877 @default.
• W2080800627 hasAuthorship W2080800627A5008642709 @default.
• W2080800627 hasAuthorship W2080800627A5014370358 @default.
• W2080800627 hasAuthorship W2080800627A5015910445 @default.
• W2080800627 hasAuthorship W2080800627A5023899503 @default.
• W2080800627 hasAuthorship W2080800627A5048904323 @default.
• W2080800627 hasAuthorship W2080800627A5052888500 @default.
• W2080800627 hasAuthorship W2080800627A5053264588 @default.
• W2080800627 hasAuthorship W2080800627A5058130022 @default.
• W2080800627 hasAuthorship W2080800627A5065815535 @default.
• W2080800627 hasAuthorship W2080800627A5071374686 @default.
• W2080800627 hasBestOaLocation W20808006271 @default.
• W2080800627 hasConcept C121608353 @default.
• W2080800627 hasConcept C126322002 @default.
• W2080800627 hasConcept C126894567 @default.
• W2080800627 hasConcept C188816634 @default.
• W2080800627 hasConcept C2776235491 @default.
• W2080800627 hasConcept C2777899217 @default.
• W2080800627 hasConcept C2779279991 @default.
• W2080800627 hasConcept C2780192828 @default.
• W2080800627 hasConcept C2989005 @default.
• W2080800627 hasConcept C509974204 @default.
• W2080800627 hasConcept C71924100 @default.
• W2080800627 hasConceptScore W2080800627C121608353 @default.
• W2080800627 hasConceptScore W2080800627C126322002 @default.
• W2080800627 hasConceptScore W2080800627C126894567 @default.
• W2080800627 hasConceptScore W2080800627C188816634 @default.
• W2080800627 hasConceptScore W2080800627C2776235491 @default.
• W2080800627 hasConceptScore W2080800627C2777899217 @default.
• W2080800627 hasConceptScore W2080800627C2779279991 @default.
• W2080800627 hasConceptScore W2080800627C2780192828 @default.
• W2080800627 hasConceptScore W2080800627C2989005 @default.
• W2080800627 hasConceptScore W2080800627C509974204 @default.
• W2080800627 hasConceptScore W2080800627C71924100 @default.
• W2080800627 hasIssue "3" @default.
• W2080800627 hasLocation W20808006271 @default.
• W2080800627 hasLocation W20808006272 @default.
• W2080800627 hasLocation W20808006273 @default.

• next